skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Obstructive sleep apnea and cardiovascular risk

(2751) Views  (300) Full article downloads

Authors: Punginathn Dorasamy

Published Date January 2007 Volume 2007:3(6) Pages 1105 - 1111
DOI: http://dx.doi.org/10.2147/TCRM.S

Punginathn Dorasamy

Pulmonary Hypertension Clinic, Hamilton Health Sciences, McMaster University, Hamilton, ON, Canada

Abstract: Obstructive sleep apnea (OSA) is a form of sleep disordered breathing characterized by episodes of apnea (during sleep) lasting at least 10 seconds per episode. The apneic periods are associated with arterial hypoxemia and disruption of normal sleep as a result of awakenings. It is increasingly being recognized that OSA is a public health hazard and there is increasing evidence that it is associated with an increase in morbidity (and possibly mortality). Patients with OSA also utilize the healthcare resources at higher rates than control patients long before their diagnosis is confirmed. Early recognition of this condition may lead to earlier treatments (eg, nasal CPAP) with reduction of the risk of cardiovascular diseases such as hypertension, ischemic heart disease, arrhythmias, platelet activation and
pulmonary hypertension.

Keywords: obstructive sleep apnea (OSA), apnea-hypopnea index (AHI), polysomnography, overlap syndrome, C-Reactive protein (CRP), sleep disordered breathing (SDB), Cheynes Stokes respiration-central sleep apnea (CSR-CSA)








Readers of this article also read:

Management of patients with newly diagnosed malignant primary brain tumors with a focus on the evolving role of temozolomide
Association between homocysteinemia and metabolic syndrome in patients with cardiovascular disease
Analysis of adherence to national nosocomial pneumonia treatment guidelines
Impact of Pharmaceutical Care interventions in the identification and resolution of drug-related problems and on quality of life in a group of elderly outpatients in Ribeirão Preto (SP), Brazil
A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD
Editorial
A case of recurrent bloody tears
Successful treatment of reactive airways dysfunction syndrome by high-dose vitamin D
Primary care for diabetes mellitus: perspective from older patients
Use of cluster analysis to describe desaturator phenotypes in COPD: correlations between pulmonary function tests and nocturnal oxygen desaturation